(S)-N-(1-((4-cyanophenyl)amino)-4-cyclopropyl-1-oxobutan-2-yl)-3-isopropyl-6,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-indole-2-carboxamide

ID: ALA5289905

Chembl Id: CHEMBL5289905

Max Phase: Preclinical

Molecular Formula: C28H34N4O3

Molecular Weight: 474.61

Associated Items:

Names and Identifiers

Canonical SMILES:  CC(C)c1c(C(=O)N[C@@H](CCC2CC2)C(=O)Nc2ccc(C#N)cc2)[nH]c2c1C(=O)CC(C)(C)C2

Standard InChI:  InChI=1S/C28H34N4O3/c1-16(2)23-24-21(13-28(3,4)14-22(24)33)31-25(23)27(35)32-20(12-9-17-5-6-17)26(34)30-19-10-7-18(15-29)8-11-19/h7-8,10-11,16-17,20,31H,5-6,9,12-14H2,1-4H3,(H,30,34)(H,32,35)/t20-/m0/s1

Standard InChI Key:  PNPQUOIZBXBAFR-FQEVSTJZSA-N

Alternative Forms

  1. Parent:

    ALA5289905

    ---

Associated Targets(Human)

MOLT-4 (49676 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
EHMT2 Tchem Histone-lysine N-methyltransferase, H3 lysine-9 specific 3 (93046 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 474.61Molecular Weight (Monoisotopic): 474.2631AlogP: 5.09#Rotatable Bonds: 8
Polar Surface Area: 114.85Molecular Species: NEUTRALHBA: 4HBD: 3
#RO5 Violations: 1HBA (Lipinski): 7HBD (Lipinski): 3#RO5 Violations (Lipinski): 1
CX Acidic pKa: 12.81CX Basic pKa: CX LogP: 4.52CX LogD: 4.52
Aromatic Rings: 2Heavy Atoms: 35QED Weighted: 0.49Np Likeness Score: -0.65

References

1. Nishigaya Y, Takase S, Sumiya T, Kikuzato K, Sato T, Niwa H, Sato S, Nakata A, Sonoda T, Hashimoto N, Namie R, Honma T, Umehara T, Shirouzu M, Koyama H, Yoshida M, Ito A, Shirai F..  (2023)  Discovery of Novel Substrate-Competitive Lysine Methyltransferase G9a Inhibitors as Anticancer Agents.,  66  (6): [PMID:36882960] [10.1021/acs.jmedchem.2c02059]

Source